LifeMDvsMerck & Company

LFMD and MRK stock compared: price, dividend, valuation and results, from SEC filings.

LFMD

LifeMD, Inc.

$2.19

Value $105M

+32.53%
LFMD's page

MRK

Merck & Company, Inc.

$147.76

Value $365B

+0.55%
MRK's page

LifeMD (LFMD) has a market value of $105M and Merck & Company (MRK) $365B. Over the last year, with dividends, LFMD moved -56.6% and MRK +66.3%. Dividend yield: LFMD none, MRK 2.30%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    LFMD$105M

    MRK$365B

    MRK is 3,469 times LFMD

  • Revenue, 12 months

    LFMD$188M

    MRK$67.4B

    MRK is 357 times LFMD

  • Net income, 12 months

    LFMD-$379.3K

    MRK$2.5B

  • Operating margin

    LFMD-11.4%

    MRK–

  • ROIC

    LFMD-202.2%

    MRK3.9%

    206.1 points apart

  • P/E

    LFMD–

    MRK148.9

  • Dividend yield

    LFMD0.0%

    MRK2.3%

    2.3 points apart

  • 5-year return

    LFMD-53.8%

    MRK+104.9%

    158.7 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

LFMD-53.8%

MRK+104.9%

10020030020222023202420252026
Returns by period
PeriodLFMDWith dividendsMRKWith dividends
1 year since November 12, 2025-56.6%Price -56.6%+66.3%Price +61.6%
3 years since November 13, 2023-69.0%-32.3% a yearPrice -69.0%+58.0%+16.5% a yearPrice +44.2%
5 years since November 12, 2021-53.8%-14.3% a yearPrice -53.8%+104.9%+15.4% a yearPrice +75.9%
10 years since November 15, 2016+76.0%+5.8% a yearPrice +76.0%+230.1%+12.7% a yearPrice +143.3%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

LFMDLifeMDMRKMerck & Company

Valuation

LFMDMRK
Valuation
Price$2.19$147.76
Market value$105M$365B
Enterprise value (EV)$83M$409B
P/E–148.9
P/E, 5-year median–14.8
P/B–8.1
EV/EBIT–86.0
Free cash flow yield–4.0%

Results and growth

LFMDMRK
Results and growth
Revenue, 12 months$188M$67.4B
Net income, 12 months-$379.3K$2.5B
Free cash flow, 12 months-$11M$14.7B
Earnings per share, 12 months-$0.02$0.98
Revenue growth, year on year25.3%1.3%
Revenue growth a year, past+39.1%over 5 years+9.4%over 5 years
EPS growth a year, past–+21.2%over 5 years

Margins and returns on capital

LFMDMRK
Margins and returns on capital
Gross margin86.7%71.8%
Operating margin-11.4%–
Net margin-0.2%3.6%
ROIC-202.2%3.9%
ROE-4.5%5.2%

Balance sheet

LFMDMRK
Balance sheet
Cash$22M$9.7B
Total debt$5.9M$53.8B
Net debt / EBITDA–5.7
Interest cover–2.4×

Dividends and buybacks

LFMDMRK
Dividends and buybacks
Dividend yield–2.3%
Dividend per share, 12 months–$3.40
Dividend growth a year, past–+5.8%over 5 years
Buyback yield0.3%1.4%
Shareholder yield0.3%3.7%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: LFMD or MRK

Didn't find what you were looking for?

Ask us
Which is bigger, LifeMD or Merck & Company?

By market value, Merck & Company ($365B) is about 3,469.2 times LifeMD ($105M), at today's prices.

How did LFMD and MRK stock do over the last 10 years?

Since November 15, 2016, LFMD's price moved +76.0% and MRK's +143.3%. With dividends: LFMD +76.0% (+5.8% a year), MRK +230.1% (+12.7% a year). Past returns do not predict future ones.

Which pays the higher dividend, LFMD or MRK?

The dividend yield at today's price is none for LifeMD and 2.30% for Merck & Company. Over the last twelve months they paid – and $3.40 per share.

Which has the higher profit margins, LifeMD or Merck & Company?

Over the last twelve months, the net margin was -0.2% for LifeMD and 3.6% for Merck & Company, and the operating margin -11.4% and –. Revenue was $188M and $67.4B.

Which is the better investment, LifeMD or Merck & Company?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.